Intraparenchymal Hemorrhage: A Fatal Presentation of Undiagnosed Acute Myelogenous Leukemia.

Autor: Hamadi R; Internal Medicine, Staten Island University Hospital, New York City, USA., Assaad M; Internal Medicine, Staten Island University Hospital, New York City, USA., Zurndorfer J; Neurology, Staten Island University Hospital, New York City, USA., El Gharib K; Internal Medicine, Staten Island University Hospital, New York City, USA., Kwok R; Oncology, Staten Island University Hospital, New York, USA., Dhar M; Hematology and Oncology, Staten Island University Hospital, New York City, USA., Schwab A; Neurology, Staten Island University Hospital, New York City, USA.
Jazyk: angličtina
Zdroj: Cureus [Cureus] 2022 Jun 02; Vol. 14 (6), pp. e25592. Date of Electronic Publication: 2022 Jun 02 (Print Publication: 2022).
DOI: 10.7759/cureus.25592
Abstrakt: We present the case of a 73-year-old patient who was admitted to the neurocritical care unit with spontaneous intracerebral hemorrhage (ICH). Upon further investigation, she was found to have hyperleukocytosis and thrombocytopenia due to acute myelogenous leukemia (AML), likely resulting in coagulopathy, vessel friability, and consequential intraparenchymal bleed. Prior reports of AML presenting with ICH are scant in the literature. As such, a heightened awareness of such a phenomenon is recommended for rapid detection and appropriate tailored management. This hopefully would, in turn, optimize outcomes.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2022, Hamadi et al.)
Databáze: MEDLINE